{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Thrasio%2C%20LLC%20D%2FB%2FA%20ZymaDerm","name":"Thrasio, LLC D/B/A ZymaDerm","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T15:58:29.386Z"},"count":1,"matches":[{"id":"cdac7fc9ac667c7a","posted_date":"2023-08-22","letter_issue_date":"2023-08-18","company_name":"Thrasio, LLC D/B/A ZymaDerm","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/cdac7fc9ac667c7a"}]}